Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

33
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
33
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

40
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
40
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

22
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GLP-1 Receptor Agonist Use Is Associated with Venous Ulcer Healing and Fewer Wound Infections.

Annals of vascular surgery·2026
Same author

Association of substance use with stroke in heart failure by community socioeconomic distress.

Drug and alcohol dependence·2025
Same author

Preventing atrial fibrillation after cardiac surgery: a single-institution cohort study after implementation of a standardized preventative protocol.

Journal of thoracic disease·2025
Same author

One-Year Outcomes in PAD Patients With Elevated Lipoprotein(a): A Propensity-Matched Analysis.

The American journal of cardiology·2025
Same author

Novel Multidisciplinary Cardiometabolic Prehabilitation for Inoperable Aortic Aneurysm Management.

JACC. Case reports·2025
Same author

Long-term Outcomes of Partial Nephrectomy Versus Percutaneous Ablation for Renal Cell Carcinoma: A Propensity-Matched Analysis.

Urology·2025
Same journal

Atrioventricular Block Induced by Right Coronary Artery Spasm in Vasospastic Angina.

JACC. Case reports·2026
Same journal

Balloon Sizing-Guided Valve Selection for Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve.

JACC. Case reports·2026
Same journal

Giant Pulmonary Artery Aneurysm in Chronic Thromboembolic Pulmonary Hypertension: Multimodality Imaging of a Rare Complication.

JACC. Case reports·2026
Same journal

Left Atrial Appendage Aneurysm and Atrial Fibrillation: A Case Report of Surgical Resection and Ablation.

JACC. Case reports·2026
Same journal

A Bailout Multiwire Technique for Retrieval of a Deployed Coronary Stent Entrapping a Guidewire.

JACC. Case reports·2026
Same journal

Traumatic Coronary Artery Dissection Treated With Prolonged Perfusion Balloon Inflation.

JACC. Case reports·2026
See all related articles

Related Experiment Video

Updated: Sep 11, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

11.7K

Integrative Lifestyle Intervention for Obesity-Related Diastolic Dysfunction: A Novel Program for Cardiac Risk

Sudha Arulalan1, Trevor Lovell2, Frank Annie1

  • 1Center for Health Services and Outcomes Research, Charleston Area Medical Center Institute for Academic Medicine, Charleston, West Virginia, USA.

JACC. Case Reports
|August 15, 2025
PubMed
Summary
This summary is machine-generated.

Strategic lifestyle interventions can improve functional status and mental well-being in patients with obesity-related cardiac conditions. A mindfulness-based virtual program led to significant weight loss and improved patient functionality.

Keywords:
cardiac riskdiastolic heart failurelifestyleobesity

More Related Videos

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.2K
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

349

Related Experiment Videos

Last Updated: Sep 11, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

11.7K
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.2K
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

349

Area of Science:

  • Cardiology
  • Obesity Medicine
  • Digital Health

Background:

  • Obesity presents a significant challenge in cardiovascular care, impacting functional status and mental well-being.
  • Obesity-related diastolic dysfunction requires effective lifestyle interventions for improved patient outcomes.

Observation:

  • A 67-year-old woman with Class II obesity and diastolic dysfunction experienced decreased functionality and chest heaviness.
  • She participated in a novel virtual care program, "Advanced Cardiac Energetics," integrating self-inquiry, mindfulness, and a heart-healthy diet.

Findings:

  • The patient achieved a 17% body weight reduction over one year.
  • Significant improvements were reported in dietary habits, energy levels, confidence, and overall functionality.
  • The program incorporated intermittent fasting and promoted natural ketosis.

Implications:

  • Innovative, technology-assisted programs combining nutrition and mindfulness may offer sustainable improvements in cardiovascular outcomes.
  • Patient empowerment through such programs is crucial for optimizing long-term cardiac care.